Ann Arbor、MIにおける心不全の臨床試験
Ann Arborとその周辺地域（約30マイル以内）の拠点で、心不全に関する22件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
被験者募集中第3相
- Research Site, Ypsilanti · 7マイル先
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
被験者募集中第3相
- Michigan Heart, PC, Ypsilanti · 7マイル先
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
被験者募集中第3相
- Trinity Health Michigan D/B/A Michigan Heart, Ypsilanti · 7マイル先
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
被験者募集中第3相
- University of Michigan Health System, Dominos Farms, Ann Arbor
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
被験者募集中第3相
- Research Site, Ypsilanti · 7マイル先
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
被験者募集中観察研究
- University of Michigan, Ann Arbor
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
被験者募集中
- University of Michigan, Ann Arbor
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
被験者募集中
- University of Michigan Hospitals, Ann Arbor
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
被験者募集中第2相
- Local Institution - 158, Ypsilanti · 7マイル先
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
被験者募集中第2/3相
- C.S. Mott Children's Hospital ( Site 0033), Ann Arbor
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
被験者募集中観察研究
- University of Michigan, Ann Arbor
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
被験者募集中観察研究
- Ypsilanti, Ypsilanti · 7マイル先
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
被験者募集中第3相
- Tenax Investigational Site, Ann Arbor
- Tenax Investigational Site, Ypsilanti · 7マイル先
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
被験者募集中第3相
- Trinity Health Michigan Heart, Ypsilanti · 7マイル先
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
被験者募集中
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Assessment of CCM in HF With Higher Ejection Fraction
被験者募集中
- University of Michigan, Ann Arbor
- Trinity health- Michigan Heart, Ypsilanti · 7マイル先
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
被験者募集中第3相
- C.S. Mott Children's Hospital - Cardiology, Ann Arbor
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
被験者募集中
- Ascension Providence Hospital Cardiology - Heart Cardiology, Howell · 25マイル先
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
被験者募集中第3相
- C.S. Mott Children's Hospital - Cardiology, Ann Arbor
Cardiovascular Health Improvement Project
被験者募集中観察研究健康なボランティア歓迎
- University of Michigan, Ann Arbor
CCM OPEN HF Registry
被験者募集中観察研究
- University of Michigan, Ann Arbor
- Trinity Ann Arbor d/b/a Michigan Heart Ann Arbor, Ypsilanti · 7マイル先
他の都市における心不全の試験
- New York City, NY51件の研究
- Boston, MA44件の研究
- Dallas, TX42件の研究
- Houston, TX36件の研究
- Cleveland, OH33件の研究
- Chicago, IL31件の研究
- Philadelphia, PA31件の研究
- San Francisco, CA29件の研究
- St. Louis, MO26件の研究
- Durham, NC26件の研究
- Kansas City, MO25件の研究
- Atlanta, GA25件の研究
Ann Arborにおける他の研究
- 前立腺がん27件の研究
- 乳がん26件の研究
- 非小細胞肺癌26件の研究
- がん（全種類）25件の研究
- 大腸癌23件の研究
- 肺がん23件の研究
- 急性骨髄性白血病17件の研究
- 心血管疾患16件の研究
- 膵臓がん14件の研究
- 悪性黒色腫12件の研究
- 腎臓がん（腎細胞がん）12件の研究
- 頭頸部扁平上皮癌12件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。